Your browser doesn't support javascript.
loading
Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson's Disease.
Palmas, Maria Francesca; Ena, Anna; Burgaletto, Chiara; Casu, Maria Antonietta; Cantarella, Giuseppina; Carboni, Ezio; Etzi, Michela; De Simone, Alfonso; Fusco, Giuliana; Cardia, Maria Cristina; Lai, Francesco; Picci, Luca; Tweedie, David; Scerba, Michael T; Coroneo, Valentina; Bernardini, Renato; Greig, Nigel H; Pisanu, Augusta; Carta, Anna R.
Afiliação
  • Palmas MF; Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
  • Ena A; Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
  • Burgaletto C; Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.
  • Casu MA; CNR Institute of Translational Pharmacology, Cagliari, Italy.
  • Cantarella G; Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.
  • Carboni E; Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
  • Etzi M; Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
  • De Simone A; Department of Pharmacy, University of Naples Federico II, Naples, Italy.
  • Fusco G; Centre for Misfolding Diseases, Department of Chemistry, University of Cambridge, Cambridge, UK.
  • Cardia MC; Department of Life and Environmental Sciences, University of Cagliari, Cagliari, Italy.
  • Lai F; Department of Life and Environmental Sciences, University of Cagliari, Cagliari, Italy.
  • Picci L; Department of Life and Environmental Sciences, University of Cagliari, Cagliari, Italy.
  • Tweedie D; Drug Design & Development Section, Translational Gerontology Branch, National Institute On Aging, National Institutes of Health, Baltimore, MD, USA.
  • Scerba MT; Drug Design & Development Section, Translational Gerontology Branch, National Institute On Aging, National Institutes of Health, Baltimore, MD, USA.
  • Coroneo V; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • Bernardini R; Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.
  • Greig NH; Drug Design & Development Section, Translational Gerontology Branch, National Institute On Aging, National Institutes of Health, Baltimore, MD, USA.
  • Pisanu A; National Research Council, Institute of Neuroscience, Cagliari, Italy. augusta.pisanu@in.cnr.it.
  • Carta AR; Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy. acarta@unica.it.
Neurotherapeutics ; 19(1): 305-324, 2022 01.
Article em En | MEDLINE | ID: mdl-35072912
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Fármacos Neuroprotetores Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Neurotherapeutics Assunto da revista: NEUROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Fármacos Neuroprotetores Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Neurotherapeutics Assunto da revista: NEUROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália